###begin article-title 0
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
###end article-title 0
###begin p 1
Conceived and designed the experiments: JPG. Performed the experiments: CM NO. Analyzed the data: CM NO JPG. Wrote the paper: JPG.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 699 706 695 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 259 262 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
Interleukin-33 (IL-33) is an IL-1-like cytokine ligand for the IL-1 receptor-related protein ST2, that activates mast cells and Th2 lymphocytes, and induces production of Th2-associated cytokines in vivo. We initially discovered IL-33 as a nuclear factor (NF-HEV) abundantly expressed in high endothelial venules from lymphoid organs, that associates with chromatin and exhibits transcriptional regulatory properties. This suggested that, similarly to IL-1alpha and chromatin-associated cytokine HMGB1, IL-33 may act as both a cytokine and a nuclear factor. Although the activity of recombinant IL-33 has been well characterized, little is known yet about the expression pattern of endogenous IL-33 in vivo.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 421 426 <span type="species:ncbi:9606">human</span>
###xml 450 455 <span type="species:ncbi:9606">human</span>
Here, we show that IL-33 is constitutively and abundantly expressed in normal human tissues. Using a combination of human tissue microarrays and IL-33 monoclonal and polyclonal antibodies, we found that IL-33 is a novel nuclear marker of the endothelium widely expressed along the vascular tree. We observed abundant nuclear expression of IL-33 in endothelial cells from both large and small blood vessels in most normal human tissues, as well as in human tumors. In addition to endothelium, we also found constitutive nuclear expression of IL-33 in fibroblastic reticular cells of lymphoid tissues, and epithelial cells of tissues exposed to the environment, including skin keratinocytes and epithelial cells of the stomach, tonsillar crypts and salivary glands.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 227 234 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 109 114 <span type="species:ncbi:9606">human</span>
Together, our results indicate that, unlike inducible cytokines, IL-33 is constitutively expressed in normal human tissues. In addition, they reveal that endothelial cells and epithelial cells constitute major sources of IL-33 in vivo. Based on these findings, we speculate that IL-33 may function, similarly to the prototype 'alarmin' HMGB1, as an endogenous 'danger' signal to alert the immune system after endothelial or epithelial cell damage during trauma or infection.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 86 89 86 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Baekkevold1">[1]</xref>
###xml 138 141 138 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 143 146 143 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Carriere1">[3]</xref>
###xml 331 334 331 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 336 339 336 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Sanada1">[4]</xref>
###xml 485 488 485 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 490 493 490 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Allakhverdi1">[5]</xref>
###xml 494 498 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Moulin1">[10]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-KomaiKoma1">[11]</xref>
###xml 587 590 587 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Sanada1">[4]</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Miller1">[12]</xref>
###xml 871 874 871 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Ali1">[7]</xref>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Chackerian1">[13]</xref>
###xml 31 34 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
IL-33 (initially designated NF-HEV for "Nuclear Factor from High Endothelial Venules" [1]) is the most recent addition to the IL-1 family [2], [3]. It has been shown to function as a ligand for the IL-1 receptor-related protein ST2 (IL-1R4), a receptor expressed on mast cells, T helper type 2 (Th2) lymphocytes and cardiomyocytes [2], [4]. Accordingly, recombinant IL-33 was found to drive production of pro-inflammatory and Th2-associated cytokines in mast cells and Th2 lymphocytes [2], [5]-[10], to induce chemotaxis of Th2 cells [11] and to protect the heart against cardiac stress [4] and atherosclerosis [12]. The effects of IL-33 were found to be abrogated in the absence of the IL-1R accessory protein (IL-1RAcP), a signaling receptor subunit that is also a member of the IL-1R complex, indicating that ST2/IL-1RAcP comprise the IL-33 signaling receptor complex [7], [13].
###end p 9
###begin p 10
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 420 423 420 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Baekkevold1">[1]</xref>
###xml 425 428 425 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Carriere1">[3]</xref>
###xml 569 576 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 576 579 576 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Carriere1">[3]</xref>
###xml 581 585 581 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Roussel1">[14]</xref>
###xml 732 735 732 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Carriere1">[3]</xref>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Roussel1">[14]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Gadina1">[15]</xref>
###xml 996 1000 988 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Dinarello1">[16]</xref>
###xml 1098 1102 1090 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Werman1">[17]</xref>
###xml 1183 1187 1175 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Agresti1">[18]</xref>
###xml 1296 1300 1288 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Scaffidi1">[19]</xref>
###xml 1301 1305 1293 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Lotze1">[21]</xref>
###xml 1362 1366 1354 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Bonaldi1">[22]</xref>
###xml 1540 1544 1528 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Bianchi1">[23]</xref>
###xml 547 550 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
Although the functional properties of recombinant IL-33 have been well characterized, little is known yet about endogenous IL-33 in vivo. Using in situ hybridization and immunohistochemistry with three distinct antisera, we previously reported that IL-33 is abundantly expressed in endothelial cells of high endothelial venules (HEVs), specialized blood vessels which mediate lymphocyte recruitment into lymphoid organs [1], [3]. We showed that IL-33 possesses transcriptional regulatory properties and associates with chromatin in the nucleus of HEV endothelial cells in vivo[3], [14]. Together, these observations suggested that IL-33 is a dual function protein that may act as both a cytokine and an intracellular nuclear factor [3], [14], [15]. A similar duality of function has previously been shown for IL-1alpha and chromatin-associated cytokine HMGB1. IL-1alpha, a cell-associated cytokine, exhibits potent pro-inflammatory cytokine activities mediated by the cell surface IL-1 receptors [16] but also functions intracellularly, by translocating to the nucleus and regulating transcription [17]. HMGB1 regulates transcription, chromatin structure and function in the nucleus [18] but also functions as a potent proinflammatory cytokine when released after tissue injury and cell necrosis [19]-[21] or actively secreted by macrophages during inflammation [22]. IL-1alpha and HMGB1 were thus defined as endogenous 'danger' signals or 'alarmins' that may alert the immune system after cell and tissue damage during trauma or infection [23].
###end p 10
###begin p 11
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 158 165 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 353 356 353 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Carriere1">[3]</xref>
###xml 379 386 379 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 656 659 656 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 785 788 785 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Sanada1">[4]</xref>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Miller1">[12]</xref>
###xml 8 11 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 298 306 <span type="species:ncbi:9606">patients</span>
So far, HEV endothelial cells constitute the only human cell type that has been shown to express endogenous IL-33 at both the mRNA and protein level in vivo. In situ hybridization studies also indicated that endothelial cells constitute a major source of IL-33 in chronically inflamed tissues from patients with rheumatoid arthritis and Crohn's disease [3]. In contrast to these in vivo analyses, real-time quantitative PCR (qPCR) studies in cultured cells revealed expression of IL-33 mRNA in arterial smooth muscle cells, bronchial epithelial cells and activated dermal fibroblasts and keratinocytes, but expression in endothelial cells was not reported [2]. Recently, studies in rodents indicated that IL-33 is expressed in the heart, by cardiac fibroblasts after mechanical stress [4] and by endothelial cells during atherosclerosis [12].
###end p 11
###begin p 12
###xml 182 189 182 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 753 757 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Bianchi1">[23]</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 314 319 <span type="species:ncbi:9606">human</span>
In the present study, we used a combination of human tissue microarrays, IL-33 monoclonal and polyclonal antibodies and blocking peptides, to analyze the expression pattern of IL-33 in vivo. We found that IL-33 is abundantly expressed in the nucleus of endothelial cells in most normal human tissues as well as in human tumors. In addition to the endothelium, high levels of nuclear IL-33 were also found in fibroblastic reticular cells (FRCs) of lymphoid tissues and certain types of epithelium, including skin keratinocytes and epithelial cells of the stomach. Based on these observations, we speculate that, similarly to HMGB1, IL-33 may function as an 'alarmin' belonging to the larger family of damage-associated molecular pattern (DAMP) molecules [23].
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Tissue microarrays
###end title 14
###begin p 15
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 141 146 <span type="species:ncbi:9606">human</span>
###xml 341 346 <span type="species:ncbi:9606">human</span>
###xml 452 457 <span type="species:ncbi:9606">human</span>
###xml 627 632 <span type="species:ncbi:9606">human</span>
Two different sources of human tissue microarrays were used in this study. High density normal tissue microarray slides containing 45 normal human tissues in duplicate (AccuMax Array # A103VI-Normal tissues) were purchased from ISU-ABXIS (Accurate Chemical Corp, Westbury, NY, USA). Normal tissue microarray slides that contain 31 different human tissues (Normal adult tissue I, # 401 1110) and tumor tissue microarray slides that contain 10 different human tumor tissues (Multitumor-10 organs # 401 2402) were purchased from Provitro-GmbH (Berlin, Germany). All slides were prepared with formaldehyde fixed, paraffin-embedded human tissues cut at 5 microm.
###end p 15
###begin title 16
Antibodies
###end title 16
###begin p 17
###xml 149 155 <span type="species:ncbi:9986">Rabbit</span>
###xml 251 257 <span type="species:ncbi:9986">rabbit</span>
###xml 298 301 <span type="species:ncbi:10116">rat</span>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
###xml 553 557 <span type="species:ncbi:9925">Goat</span>
###xml 585 591 <span type="species:ncbi:9986">rabbit</span>
###xml 652 657 <span type="species:ncbi:10090">mouse</span>
IL-33 mAb (1/200, clone Nessy-1) and polyclonal antibodies (1/200, Cter1 and Cter2, nos 210-447 and 210-933) were obtained from Alexis Biochemicals. Rabbit polyclonal antibodies against CD31 (1/100, Abcam), vWF (1/100, Dako) and desmin (1/75, Abcam), rabbit mAb anti-CD3 (1/100, clone SP7, Abcam), rat IgM mAb MECA-79 (1/200, Pharmingen), and mouse mAbs against alpha smooth-muscle cell actin (1/100, clone 1A4, Dako), fascin (1/100, clone 55K2, Dako) and CD68 (1/200, clone PG-M1, Dako), were used as primary antibodies in double staining experiments. Goat polyclonal antibodies anti-rabbit (1/200, Cy3, Amersham; Alexa 488, Molecular Probes) or anti-mouse (1/200, Cy3 or Cy2, Amersham; Biotin, Vector Laboratories) were used as secondary reagents.
###end p 17
###begin title 18
Immunohistochemistry and immunofluorescence staining
###end title 18
###begin p 19
###xml 245 246 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 248 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 492 496 <span type="species:ncbi:9925">Goat</span>
5 microm paraffin sections were deparaffinized in Histo-clear (National Diagnostics, MERCK Eurolab s.a) and rehydrated in graded alcohol series. For staining revealed through peroxydase activity, endogenous peroxydase was inhibited using 0.03% H2O2 in Methanol, 30 mn. The sections were then washed in distilled water and boiled in a microwave oven for epitope retrieval in Sodium Citrate buffer (10 mM pH 6, 20 mn). Slides were equilibrated in PBS and incubated with blocking solution (PBS, Goat serum 5%, BSA 5%) 1 h at room temperature. When biotinylated secondary antibody was used, endogenous biotin was inhibited using an avidin/biotin blocking kit from Vector. Primary antibodies were diluted in PBS, BSA 1% and incubated overnight at 4degreesC. For immunofluorescence detection, the sections were washed in PBS for 30 mn and incubated with secondary antibodies coupled to Cy3 or Cy5 diluted in PBS, BSA 1%, 1 h at room temperature. The sections were then washed in PBS for 30 mn and counterstained with Dapi and mounted in Mowiol embedding medium. For immunoperoxydase detection, the sections were washed in PBS for 30 mn and incubated with biotinylated secondary antibodies diluted in PBS, BSA 1%, 1 h at room temperature. The sections were then washed in PBS for 30 mn and incubated with Streptavidin peroxydase (Dako) diluted 1/100 in PBS, BSA 1% for 45 mn at room temperature. Peroxydase activity was revealed using DAB substrate (Sigma), slides were counterstained with Methyl Green (Sigma) or Hematoxylin (Sigma), then dehydrated and mounted in Safemount embedding medium (Labonord, France). For peptide-blocking experiments, the IL-33 mAb and polyclonal antibodies were adsorbed with control or IL-33 peptide (no 522-098, Alexis Biochemicals) for 1 h at 37degreesC.
###end p 19
###begin title 20
Image acquisition and processing
###end title 20
###begin p 21
Fluorescent images were visualized using an inverted microscope Eclipse TE300 Nikon with 40X/0.75 and 100X/0.5-1.3 objectives at room temperature and captured through a DXM 1200 digital camera using Nikon ACT1 software. Brightfield images were visualized using an Eclipse 80i Nikon microscope with 40X/0.75 and 100X/1.30 objectives at room temperature and captured through a Digital Sight DS 5 M L1 Nikon camera using DS 5 M L1 Nikon software. All images were processed using Adobe Photoshop CS2 software.
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
###xml 70 75 <span type="species:ncbi:9606">human</span>
IL-33 is constitutively expressed in both HEVs and FRCs networks from human secondary lymphoid tissues
###end title 23
###begin p 24
###xml 304 321 304 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g001">Figure 1, A and B</xref>
###xml 336 339 336 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Carriere1">[3]</xref>
###xml 575 592 575 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g001">Figure 1, C and D</xref>
###xml 705 722 705 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g001">Figure 1, E and F</xref>
###xml 896 905 896 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g001">Figure 1G</xref>
###xml 921 930 921 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g001">Figure 1H</xref>
###xml 1176 1193 1176 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g001">Figure 1, I and J</xref>
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 281 284 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
###xml 529 535 <span type="species:ncbi:9986">rabbit</span>
###xml 747 750 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
A mouse mAb against human IL-33 (mouse IgG1, clone Nessy), suitable for immunohistochemical staining, recently became available. Immunohistochemical and immunofluorescence staining of human tonsil sections with this mAb confirmed the abundant expression of IL-33 in the nucleus of HEV endothelial cells (Figure 1, A and B), as expected [3]. Interestingly, nuclear staining of scattered single cells in the interfollicular T cell areas was also observed. This staining was specific since, it was also observed with the anti-IL-33 rabbit polyclonal antibodies Cter1 and Cter2 (Figure 1, C and D) and it was abrogated by pre-incubating the IL-33 mAb and polyclonal antibodies with recombinant IL-33 peptide (Figure 1, E and F). Moreover, staining of HEV blood vessels and isolated cells in the interfollicular T-cell areas was also observed in other secondary lymphoid tissues, such as lymph nodes (Figure 1G) and appendix (Figure 1H). Interestingly, the localization of IL-33 in the nuclei of the isolated cells was not homogenous and, similarly to HEVs, higher magnification revealed co-localization with chromatin-rich domains that contained high local concentrations of DNA (Figure 1, I and J).
###end p 24
###begin title 25
###xml 75 80 <span type="species:ncbi:9606">human</span>
IL-33 is a chromatin-associated nuclear factor constitutively expressed in human secondary lymphoid tissues by HEVs and isolated cells in the interfollicular T cells areas.
###end title 25
###begin p 26
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 134 137 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
###xml 557 560 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
###xml 740 745 <span type="species:ncbi:9606">human</span>
A: Immunohistochemical staining of a human tonsil section with IL-33 mAb Nessy-1. B-D: Double staining of human tonsils sections with HEV-specific mAb MECA79 (green) and IL-33 mAb Nessy-1 (B, red) or two distinct IL-33 polyclonal antisera, Cter1 (C, red) or Cter2 (D, red). The follicles (fol) are indicated. E and F: Nuclear staining of HEVs and isolated cells in the T cell areas was abrogated by pre-incubating the IL-33 monoclonal (E) and polyclonal (F) antibodies with IL-33 peptides but not control peptides. G and H: Nuclear accumulation of IL-33 in HEV blood vessels and isolated cells was also observed in lymph node (G, IL-33 mAb, red; CD31, green) and appendix (H, IL-33 mAb, red; vWF, green). I and J: Higher magnification of a human tonsil section double-stained with IL-33 and MECA-79 antibodies and counterstained with the DNA-binding dye DAPI. In the nucleus of both HEVs (arrow, upper panel) and isolated cells (arrowhead, lower panel), IL-33 accumulates in nuclear domains that colocalize with dense regions of DAPI staining (J), indicating association with chromatin. Magnification bars: A, I 10 microm; B, G, H 20 microm; J 5 microm; C, D, E, F 60 microm.
###end p 26
###begin p 27
###xml 202 219 202 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g002">Figure 2, A and B</xref>
###xml 247 256 247 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g002">Figure 2C</xref>
###xml 537 541 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-ToccanierPelte1">[24]</xref>
###xml 543 547 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Bajenoff1">[25]</xref>
###xml 604 605 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 612 625 612 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g002">Figure 2, D&#8211;F</xref>
###xml 748 752 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-ToccanierPelte1">[24]</xref>
###xml 754 767 746 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g002">Figure 2, G&#8211;I</xref>
###xml 819 820 811 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 843 844 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 943 948 <span type="species:ncbi:9606">human</span>
###xml 1089 1094 <span type="species:ncbi:9606">human</span>
In an effort to identify the isolated cells in the T cell areas, we then performed double staining of human tonsil sections with IL-33 mAb or polyclonal antibodies, and antibodies against T cells (CD3, Figure 2, A and B), dendritic cells (fascin, Figure 2C) or macrophages (CD68, data not shown). However, we did not observe colocalization of IL-33 with any of these markers. We next examined the possibility that these cells may correspond to stromal cells. Strikingly, double staining with an antibody against desmin, a marker of FRCs [24], [25], revealed accumulation of IL-33 in the nucleus of desmin+ FRCs (Figure 2, D-F). This was confirmed using an antibody against alpha-smooth muscle actin (alpha-SMA), a marker of myofibroblasts and FRCs [24] (Figure 2, G-I). It is important to note, however, that the desmin+ FRCs and the alpha-SMA+ FRCs did not always overlap, and IL-33 accumulated in the nucleus of many, but not all, FRCs from human tonsils. We concluded from these studies that IL-33 is a chromatin-associated nuclear factor constitutively expressed in HEVs and FRCs from human secondary lymphoid tissues.
###end p 27
###begin title 28
IL-33 is a nuclear marker of FRCs in the interfollicular T cells areas.
###end title 28
###begin p 29
###xml 504 505 504 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 859 860 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 265 270 <span type="species:ncbi:9606">human</span>
###xml 539 544 <span type="species:ncbi:9606">human</span>
###xml 683 686 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
###xml 732 735 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
A and B: Double staining of human tonsils sections with IL-33 mAb Nessy-1 (red) and anti-CD3 polyclonal antibody (green). C: Double staining of a human tonsil section with IL-33 polyclonal antibody Cter2 (green) and anti-fascin mAb (red). D-F: Double staining of a human tonsil section with IL-33 mAb Nessy-1 (red) and anti-desmin polyclonal antibody (green). A follicle is indicated (fol). Higher magnification (E) and DAPI counterstaining (F) are shown to reveal nuclear accumulation of IL-33 in desmin+ cells. G-I: Double staining of a human tonsil section with IL-33 polyclonal antibody Cter2 (green) and anti-alpha-SMA mAb (red). alpha-SMA is detected in the basal lamina of an HEV blood vessel (G) but is not expressed by the HEV endothelial cells. Higher magnification (H) and DAPI counterstaining (I) reveals nuclear accumulation of IL-33 in alpha-SMA+ cells. Magnification bars: A, D 60 microm; B, C, G 25 microm; E, F, H, I 10 microm.
###end p 29
###begin title 30
IL-33 is a nuclear marker of the endothelium with widespread expression along the vascular tree
###end title 30
###begin p 31
###xml 242 251 242 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona fide</italic>
###xml 502 510 502 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g003">Figure 3</xref>
###xml 1249 1256 1249 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1258 1278 1258 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g003">Figure 3, arrowheads</xref>
###xml 1377 1380 1377 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 1605 1613 1605 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g004">Figure 4</xref>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 487 492 <span type="species:ncbi:9606">human</span>
To determine the expression profile and potential cellular sources of IL-33 in non-lymphoid tissues, we stained human tissues microarrays (>50 human tissues) with IL-33 antibodies. We used two independent sources of tissue arrays to obtain a bona fide expression profile independent of the individuals analyzed and the type and method of preparation of the microarrays. Interestingly, this analysis revealed constitutive and widespread expression of IL-33 in the endothelium from normal human tissues (Figure 3). Specific accumulation of IL-33 in the nucleus of endothelial cells from large blood vessels was found in most tissues, as revealed by double staining with antibodies against endothelial cell markers CD31 or von willebrand factor (vWF). Similarly to the staining of HEVs and FRCs in lymphoid tissues, staining of endothelial cells nuclei with IL-33 antibodies in non-lymphoid tissues was specific since it was observed with both IL-33 mAb and polyclonal antibodies, and it was abrogated by pre-incubating the antibodies with recombinant IL-33 (data not shown). In contrast to the endothelial cells that constitutively expressed high levels of IL-33 protein, vascular smooth muscle cells from arterial blood vessels did not express IL-33 in vivo (Figure 3, arrowheads), despite the fact IL-33 mRNA expression has previously been detected in arterial SMCs in culture [2]. In the microvasculature of many tissues, including liver, skeletal muscle, kidney (peritubular capillaries), prostate and skin, expression of IL-33 was observed in the nucleus of endothelial cells from small blood vessels (Figure 4). However, some heterogeneity was found since IL-33 was not detected in the microcirculation of the brain and kidney glomeruli (data not shown). Together, these results indicated that IL-33 is a novel nuclear marker of the endothelium with widespread expression along the vascular tree.
###end p 31
###begin title 32
###xml 105 110 <span type="species:ncbi:9606">human</span>
IL-33 is constitutively expressed in the nucleus of endothelial cells from large blood vessels in normal human tissues.
###end title 32
###begin p 33
###xml 23 28 <span type="species:ncbi:9606">human</span>
Expression of IL-33 in human tissues was analyzed using both immunohistochemistry (lefts panels) and immunofluorescence staining (right panels). Double staining was performed with IL-33 mAb Nessy-1 (red) and anti-CD31 or anti-vWF polyclonal antibodies (green). DNA was counter-stained with DAPI. Arrowheads label the nuclei of smooth muscle cells in arterioles that are not stained with IL-33 antibodies. Magnification bars: 35 microm.
###end p 33
###begin title 34
###xml 105 110 <span type="species:ncbi:9606">human</span>
IL-33 is constitutively expressed in the nucleus of endothelial cells from small blood vessels in normal human tissues.
###end title 34
###begin p 35
Expression of IL-33 in the microvasculature was analyzed using immunofluorescence staining. Double staining was performed with IL-33 mAb Nessy-1 (red) and anti-CD31 or anti-vWF polyclonal antibodies (green). DNA was counter-stained with DAPI. Magnification bars: 20 microm.
###end p 35
###begin title 36
###xml 78 83 <span type="species:ncbi:9606">human</span>
IL-33 is abundantly expressed in the nucleus of endothelial cells in multiple human tumor tissues
###end title 36
###begin p 37
###xml 204 212 204 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g005">Figure 5</xref>
###xml 275 276 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 356 371 356 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g005">Figure 5A and B</xref>
###xml 383 398 383 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g005">Figure 5C and D</xref>
###xml 408 423 408 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g005">Figure 5E and F</xref>
###xml 436 451 436 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g005">Figure 5G and H</xref>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 120 125 <span type="species:ncbi:9606">human</span>
We then asked whether IL-33 is expressed in blood vessels from human tumor tissues. For that purpose, we double-stained human multi-tumor tissue microarrays with antibodies against IL-33 and CD31 or vWF (Figure 5). We found abundant expression of IL-33 in the nucleus of CD31+ or vWF+ endothelial cells from blood vessels in adenocarcinomas of the kidney (Figure 5A and B), stomach (Figure 5C and D), liver (Figure 5E and F), pancreas (Figure 5G and H), lung, breast or colon (data not shown). Therefore, IL-33 appeared to be a general nuclear marker of the endothelium expressed in both normal and tumor tissues.
###end p 37
###begin title 38
###xml 69 74 <span type="species:ncbi:9606">human</span>
IL-33 is abundantly expressed in the nucleus of endothelial cells in human tumor tissues.
###end title 38
###begin p 39
###xml 37 42 <span type="species:ncbi:9606">human</span>
Expression of IL-33 in the indicated human tumor tissues was analyzed using immunofluorescence staining. Double staining was performed with IL-33 mAb Nessy-1 (red) and anti-CD31 or anti-vWF polyclonal antibodies (green). DNA was counter-stained with DAPI. Magnification bars: A,B,G,H 50 microm; C,D,E,F 20 microm.
###end p 39
###begin title 40
IL-33 is constitutively expressed in the nucleus of epithelial cells in tissues exposed to the environment
###end title 40
###begin p 41
###xml 278 291 278 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g006">Figure 6, A&#8211;C</xref>
###xml 338 351 338 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g006">Figure 6, D&#8211;F</xref>
###xml 373 390 373 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g006">Figure 6, G and H</xref>
###xml 497 506 497 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g006">Figure 6I</xref>
In many tissues, IL-33 expression appeared to be restricted to endothelial cells. However, in certain tissues exposed to the environment, high levels of IL-33 were also found in the nucleus of epithelial cells. For instance, IL-33 expression was detected in skin keratinocytes (Figure 6, A-C), in epithelial cells of the mucosal surface (Figure 6, D-F) and gastric glands (Figure 6, G and H) in the stomach, as well as in epithelial cells of tonsillar crypts (data not shown) and salivary glands (Figure 6I). Although IL-33 staining in skin keratinocytes and epithelial cells of the stomach was consistently observed in all samples analyzed, significant variability was noted between different cells, between different parts of the tissues and between different individuals, suggesting modulation of IL-33 expression by local environmental cues.
###end p 41
###begin title 42
IL-33 is constitutively expressed in the nucleus of epithelial cells in tissues exposed to the environment.
###end title 42
###begin p 43
A-C: Skin keratinocytes; D-F: Epithelial cells of the mucosal surface in the stomach; G-H: Epithelial cells of the gastric glands in the stomach; I: Epithelial cells of the salivary glands. Immunohistochemical and immunofluorescence staining were performed with IL-33 mAb Nessy-1. For immunofluorescence, IL-33 expression was detected in red and DNA was counter-stained with DAPI (blue). Magnification bars: 70 microm.
###end p 43
###begin p 44
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 100 108 100 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003331-g003">Figure 3</xref>
###xml 609 616 609 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 696 699 696 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 537 542 <span type="species:ncbi:9606">human</span>
As discussed above, IL-33 was not constitutively expressed in vascular smooth muscle cells in vivo (Figure 3). It was also not found in the nucleus of cardiac or skeletal muscle myocytes. However, nuclear expression of IL-33 was observed in visceral smooth muscle cells of the gastrointestinal and urogenital tracts, although it was less intense than in endothelial or epithelial cells (data not shown). Similarly, with the exception of FRCs in lymphoid tissues, expression of IL-33 was generally not detected in fibroblasts from normal human tissues. For instance, IL-33 was not observed in skin fibroblasts in vivo, despite the presence of IL-33 mRNA in activated dermal fibroblasts in culture [2].
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Allakhverdi1">[5]</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-KomaiKoma1">[11]</xref>
###xml 200 207 200 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 695 698 695 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Baekkevold1">[1]</xref>
###xml 700 703 700 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Carriere1">[3]</xref>
###xml 1194 1201 1194 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1201 1204 1201 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Baekkevold1">[1]</xref>
###xml 1206 1209 1206 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Carriere1">[3]</xref>
###xml 236 241 <span type="species:ncbi:9606">human</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
###xml 813 818 <span type="species:ncbi:9606">human</span>
###xml 941 946 <span type="species:ncbi:9606">human</span>
Although the capacity of IL-33 to activate the ST2 receptor expressed on Th2 cells and mast cells has been well established [2], [5]-[11], very little is known yet about the cellular sources of IL-33 in vivo. In the present work, using human tissue microarrays and IL-33 monoclonal and polyclonal antibodies, we demonstrate that IL-33 is constitutively expressed in the nucleus of endothelial cells from both large and small blood vessels in most tissues analyzed (>50 human tissues). These observations, which extend our previous data that revealed expression of IL-33 in endothelial cells from lymphoid tissues, chronically inflamed rheumatoid arthritis synovium and Crohn's disease intestine [1], [3], demonstrate that IL-33 is a novel nuclear marker of the endothelium in both normal and chronically inflamed human tissues. Moreover, abundant expression of IL-33 was also observed in the nucleus of endothelial cells in several distinct human tumors, indicating that IL-33 is a marker of tumor blood vessels as well. Together, these findings provide further support to the possibility that IL-33 may play important roles as a chromatin-associated factor in the nucleus of endothelial cells in vivo[1], [3].
###end p 46
###begin p 47
###xml 442 446 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Dinarello1">[16]</xref>
###xml 448 452 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Hauser1">[26]</xref>
###xml 454 458 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Mizutani1">[27]</xref>
In addition to endothelium, we detected abundant expression of IL-33 in the nucleus of epithelial cells of tissues in contact with the environment, including the skin and gastrointestinal tract, where pathogens, allergens and other environmental agents are frequently encountered. Interestingly, constitutive expression in skin keratinocytes has previously been reported for other members of the IL-1 family, including IL-1alpha and IL-1beta [16], [26], [27]. The constitutive expression of IL-33 in epithelial barriers of our body thus supports the possibility that, similarly to the IL-1s, it may play important roles in the response to injury or infection.
###end p 47
###begin p 48
###xml 67 74 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 442 445 442 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 577 584 577 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 584 587 584 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Carriere1">[3]</xref>
###xml 778 782 778 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Bonaldi1">[22]</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Scaffidi1">[19]</xref>
###xml 970 973 970 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 1066 1067 1066 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1085 1086 1085 1086 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1115 1116 1115 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1249 1256 1249 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1468 1472 1468 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Bianchi1">[23]</xref>
###xml 1605 1608 1605 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 1610 1613 1610 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Allakhverdi1">[5]</xref>
###xml 1614 1617 1614 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Ali1">[7]</xref>
###xml 1773 1777 1773 1777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Galli1">[28]</xref>
###xml 2067 2071 2067 2071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Galli1">[28]</xref>
###xml 2432 2435 2432 2435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Allakhverdi1">[5]</xref>
###xml 2437 2441 2437 2441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Soumelis1">[29]</xref>
###xml 2443 2447 2443 2447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Allakhverdi2">[30]</xref>
###xml 902 907 <span type="species:ncbi:9606">human</span>
In all endothelial cells and epithelial cells that expressed IL-33 in vivo, the protein accumulated in the nucleus and we found no evidence for cytoplasmic, membrane or extracellular localization. Therefore, it is not yet clear how IL-33 may be released from the nucleus to exert its cytokine activities towards target cells expressing the ST2 receptor. The mature form of IL-33 has been proposed to be secreted after maturation by caspase-1 [2], but the predicted cleavage site for caspase-1 is not conserved in IL-33 orthologues and we found no evidence for IL-33 processing in vivo[3]. Two mechanisms have previously been shown to be involved in the release of chromatin-associated cytokine HMGB1, secretion by activated macrophages after hyperacetylation of lysine residues [22] or passive release by necrotic cells during cell damage or tissue injury [19]. Significant expression of IL-33 mRNA in human hematopoietic cells was not detected in previous qPCR studies [2], and accordingly, in the present work, we did not observe expression of IL-33 protein in CD3+ lymphocytes, CD68+ tissue macrophages or Fascin+ dendritic cells. Therefore, active secretion by macrophages or dendritic cells is unlikely to be a major mechanism of IL-33 release in vivo. An alternative and more likely possibility is that IL-33 may be released from dead or dying cells during trauma or infection, and may function, similarly to HMGB1, as an endogenous 'danger' signal or 'alarmin' [23], to alert the immune system of cell or tissue damage. In this respect, mast cells, that constitute a major cellular target of IL-33 [2], [5]-[7] and are strategically positioned closed to vessel walls and epithelial surfaces exposed to the environment (including the skin and gastrointestinal tract) [28], could play an important role in the response to the IL-33 'alarmin' signal released by damaged endothelial or epithelial cells. Mast cells are widely recognized for their roles as effector cells in allergic disorders, but are also important as initiators and effectors of innate immunity [28], and IL-33 may turn out to be a critical activator of mast cells during innate immune response to pathogens. IL-33 could act alone or in concert with other mediators, such as thymic stromal lymphopoietin (TSLP), which is also expressed by inflamed skin and tonsillar crypt epithelium, and can be released by epithelial cells in response to trauma or infection [5], [29], [30].
###end p 48
###begin p 49
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Brunner1">[31]</xref>
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Shimpo1">[32]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Weinberg1">[33]</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Tajima1">[34]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Oshikawa1">[35]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Kuroiwa1">[36]</xref>
###xml 239 244 <span type="species:ncbi:9606">human</span>
###xml 839 844 <span type="species:ncbi:9606">human</span>
###xml 1100 1105 <span type="species:ncbi:9606">human</span>
The possibility that IL-33 may play important roles in the response to trauma and infection is further supported by the observation that increased serum levels of a soluble form of the IL-33 receptor ST2 have been associated with numerous human diseases, including sepsis and trauma [31], acute myocardial infarction [32], chronic heart failure [33], idiopathic pulmonary fibrosis [34], asthma and allergic airway inflammation [35], rheumatoid arthritis and systemic lupus erythematosus [36]. The increase in serum levels of soluble ST2 likely results from the activation (or recruitment) by IL-33 of target cells co-expressing the membrane and secreted forms of the ST2 receptor, thus providing evidence for IL-33 release (or activation) in all these diseases. Our observations that demonstrate constitutive expression of IL-33 in normal human tissues are therefore important, because they suggest IL-33 can potentially be released in any tissue after injury (after endothelial or epithelial cell damage), and this could explain why the IL-33/ST2 signaling system appears to be involved in numerous human diseases affecting many different organs.
###end p 49
###begin p 50
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Bajenoff1">[25]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Link1">[37]</xref>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Link1">[37]</xref>
###xml 474 478 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Luther1">[38]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-KomaiKoma1">[11]</xref>
###xml 1007 1011 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Bajenoff1">[25]</xref>
###xml 1013 1017 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Link1">[37]</xref>
###xml 1019 1023 1015 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Tomasek1">[39]</xref>
###xml 1025 1029 1021 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Hinz1">[40]</xref>
###xml 1061 1062 1057 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1293 1296 1289 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Sanada1">[4]</xref>
###xml 1557 1561 1553 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Tomasek1">[39]</xref>
###xml 1563 1567 1559 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Hinz1">[40]</xref>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 757 760 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
###xml 1225 1228 <span type="species:ncbi:10116">rat</span>
Although IL-33 was generally not detected in fibroblasts from normal human tissues, it was found to be constitutively expressed in the nucleus of T-zone FRCs of lymphoid tissues. FRCs play critical roles in lymph node organization and function by modulating lymphocyte survival and migration within T-cell areas [25], [37]. FRCs have been found to be major sources of cytokines and chemokines, such as the pro-survival factor IL-7 and the CCR7 ligands CCL19 and CCL21 [37], [38]. Our observations indicate that T-zone FRCs also constitute a major cellular source of IL-33 in secondary lymphoid organs. An intriguing possibility is that IL-33, which exhibits chemotactic properties for Th2 lymphocytes [11], may modulate migration of Th2 lymphocytes through HEV walls and FRC networks within T-cell areas in lymph nodes during infection. T-zone FRCs have been shown to exhibit myofibroblastic features, including the expression of alpha-SMA that is associated with increased generation of contractile forces [25], [37], [39], [40]. The expression of IL-33 in SMA+ FRCs may therefore be linked to their contractile myofibroblastic phenotype. Interestingly, IL-33 expression has also been shown to be biomechanically-induced in rat cardiac fibroblasts during their conversion into myofibroblasts [4]. Specific expression in fibroblasts with myofibroblast characteristics suggests involvement of IL-33 in normal and pathological wound healing, tissue fibrosis and connective-tissue remodeling after injury, processes in which myofibroblasts play critical roles [39], [40].
###end p 50
###begin p 51
###xml 220 228 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 228 231 228 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Schmitz1">[2]</xref>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Onda1">[41]</xref>
###xml 747 750 747 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Sanada1">[4]</xref>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Onda1">[41]</xref>
###xml 1032 1035 1032 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Sanada1">[4]</xref>
###xml 1037 1041 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Shimpo1">[32]</xref>
###xml 1043 1047 1043 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Weinberg1">[33]</xref>
###xml 1049 1053 1049 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003331-Weinberg2">[42]</xref>
###xml 120 125 <span type="species:ncbi:9606">human</span>
Surprisingly, we did not find expression of IL-33 in vascular smooth muscle cells from arterial blood vessels in normal human tissues, although expression in these cells has previously been reported using cultured cells in vitro[2]. Expression in cultured cells could result from a contractile phenotype biomechanically induced by culture of the cells on plastic. In support of this possibility, the mRNA encoding the canine orthologue of IL-33 (DVS27), has been found to be strongly upregulated during cerebral vasospasm, a complex pathological process characterized by prolonged contraction of arterial smooth muscle cells [41]. The apparent association of IL-33 expression with contractile forces in both smooth muscle cells and myofibroblasts [4], [41], supports an important role of IL-33 in the response to tissue injury, in addition to its roles in the response to infection. For instance, the IL-33/ST2 signaling system may be particularly important in the heart response to stress and injury during cardiovascular diseases [4], [32], [33], [42].
###end p 51
###begin p 52
###xml 701 708 701 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 589 594 <span type="species:ncbi:9606">human</span>
In summary, the results presented in this manuscript are important because they demonstrate constitutive expression of IL-33 in the nucleus of endothelial cells and epithelial cells in normal human tissues. Based on this tissue distribution, we speculate that IL-33 may function as an endogenous 'alarmin', similarly to chromatin-associated cytokine HMGB1, to alert the immune system of tissue injury or infection. Future studies should aim at determining the mechanisms of IL-33 release and presentation to the IL-33 signaling receptor complex, and defining the precise roles of IL-33 in human health and disease, including its functions at the level of chromatin in the nucleus of endothelial cells in vivo.
###end p 52
###begin title 53
References
###end title 53
###begin article-title 54
###xml 33 36 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
###xml 83 88 <span type="species:ncbi:9606">human</span>
Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.
###end article-title 54
###begin article-title 55
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
###end article-title 55
###begin article-title 56
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.
###end article-title 56
###begin article-title 57
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
###end article-title 57
###begin article-title 58
###xml 79 84 <span type="species:ncbi:9606">human</span>
Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells.
###end article-title 58
###begin article-title 59
###xml 64 69 <span type="species:ncbi:9606">human</span>
IL-33 can promote survival, adhesion and cytokine production in human mast cells.
###end article-title 59
###begin article-title 60
IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.
###end article-title 60
###begin article-title 61
Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation.
###end article-title 61
###begin article-title 62
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.
###end article-title 62
###begin article-title 63
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.
###end article-title 63
###begin article-title 64
###xml 31 36 <span type="species:ncbi:9606">human</span>
IL-33 is a chemoattractant for human Th2 cells.
###end article-title 64
###begin article-title 65
IL-33 reduces the development of atherosclerosis.
###end article-title 65
###begin article-title 66
IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex.
###end article-title 66
###begin article-title 67
Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket.
###end article-title 67
###begin article-title 68
###xml 9 14 <span type="species:ncbi:9940">sheep</span>
IL-33: a sheep in wolf's clothing?
###end article-title 68
###begin article-title 69
Biologic basis for interleukin-1 in disease.
###end article-title 69
###begin article-title 70
The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.
###end article-title 70
###begin article-title 71
HMGB proteins and gene expression.
###end article-title 71
###begin article-title 72
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.
###end article-title 72
###begin article-title 73
###xml 51 55 <span type="species:ncbi:10090">mice</span>
HMG-1 as a late mediator of endotoxin lethality in mice.
###end article-title 73
###begin article-title 74
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.
###end article-title 74
###begin article-title 75
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.
###end article-title 75
###begin article-title 76
DAMPs, PAMPs and alarmins: all we need to know about danger.
###end article-title 76
###begin article-title 77
Characterization of stromal cells with myoid features in lymph nodes and spleen in normal and pathologic conditions.
###end article-title 77
###begin article-title 78
Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes.
###end article-title 78
###begin article-title 79
###xml 35 40 <span type="species:ncbi:9606">human</span>
Interleukin 1 is present in normal human epidermis.
###end article-title 79
###begin article-title 80
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes.
###end article-title 80
###begin article-title 81
Mast cells in the development of adaptive immune responses.
###end article-title 81
###begin article-title 82
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.
###end article-title 82
###begin article-title 83
###xml 44 49 <span type="species:ncbi:9606">human</span>
Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells.
###end article-title 83
###begin article-title 84
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma.
###end article-title 84
###begin article-title 85
Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction.
###end article-title 85
###begin article-title 86
Identification of serum soluble ST2 receptor as a novel heart failure biomarker.
###end article-title 86
###begin article-title 87
The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis.
###end article-title 87
###begin article-title 88
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation.
###end article-title 88
###begin article-title 89
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Identification of human ST2 protein in the sera of patients with autoimmune diseases.
###end article-title 89
###begin article-title 90
Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells.
###end article-title 90
###begin article-title 91
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse.
###end article-title 91
###begin article-title 92
Myofibroblasts and mechano-regulation of connective tissue remodelling.
###end article-title 92
###begin article-title 93
The myofibroblast: one function, multiple origins.
###end article-title 93
###begin article-title 94
Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage.
###end article-title 94
###begin article-title 95
Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.
###end article-title 95
###begin p 96
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 96
###begin p 97
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from Ligue Nationale contre le Cancer (Equipe labellisee), ANR-programme blanc "Cuboidale", Region Midi-Pyrenees and MAIN European Network of Excellence (FP6-502935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 97

